Drawing for NTX

USPTO serial 97575821

NTX

Reviewed by CopyMark Law Group

Reg. 7445687Status 700Registered
Filing date
Status date
Registration date
Jul 16, 2024
Examiner
TAYLOR, SLOAN H
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with NTX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Rebeccah Gan

Rebeccah Gan MUNCY, GEISSLER, OLDS & LOWE, P.C.125 S. Royal St.Alexandria, VA 22314UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
009Downloadable application software in the field of health for collecting, analyze, monitor and manage data to prevent, manage and treat chronic pain and medical disorder or disease; downloadable computer application software for measuring, analyzing, preventing, relieving and managing pain; downloadable computer software for use in medical electronic database management; downloadable medical database software for use in managing pain symptoms and providing information on how pain works; downloadable medical database management software; downloadable virtual reality, augmented reality and mixed reality software for mobile devices that integrate electronic data for use in measuring, analyzing, preventing, relieving and managing painACTIVE—
010Pain measuring device for medical use; pain analysis device for medical use; all the aforementioned goods are related to digital therapeutics and neurosciences and exclude the domains of nanomedicine, nanosciences and nanotechnologyACTIVE—
035Database management and compilation of information into medical computer databases in connection with pain; records management services, namely, management of individual medical files and records for healthcare professionals for business purposesACTIVE—
038Provision of access to medical computer databases in connection with pain via computer networks; Providing access to electronic sites in the nature of health service platforms for analysis, processing and sharing of pain-related informationACTIVE—
041Developing training systems and learning methodologies for others in the field of measuring and relieving pain in an autonomous manner; Medical teaching and training services relating to pain analysis; Medical teaching and training services relating to therapeutic treatments against pain; medical teaching and training services for transmitting methods for measuring and relieving pain in an autonomous mannerACTIVE—
042Development of medical databases; Computer software development and testing of computer software for methods and algorithms for measuring, analyzing, preventing, relieving and managing pain; Software as a service (SAAS) services featuring software for collecting, analyze, monitor and manage data to prevent, manage and treat chronic pain and medical disorder or disease in the field of health; design, development and maintenance of application software in the field of health; Providing temporary use of on-line non-downloadable computer software applications in the field of health accessible through a website for collecting, analyze, monitor and manage data to prevent, manage and treat chronic pain and medical disorder or disease; all the aforementioned goods are related to digital therapeutics and neurosciences and exclude the domains of nanomedicine, nanosciences and nanotechnologyACTIVE—
044Health care services, namely, providing therapeutic treatment of pain; health care services, namely, providing therapeutic treatment of pain via the internet; medical diagnostic services relating to pain; information services relating to medical care and health services to combat pain; all the aforementioned goods are related to digital therapeutics and neurosciences and exclude the domains of nanomedicine, nanosciences and nanotechnologyACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 16, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jul 16, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 16, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 30, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 30, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 10, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 21, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 21, 2024XAECEXAMINER'S AMENDMENT ENTERED—
Mar 21, 2024GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 21, 2024GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 21, 2024CNEAEXAMINERS AMENDMENT -WRITTEN—
Nov 20, 2023GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Nov 20, 2023GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Nov 20, 2023CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 27, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 26, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 26, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 27, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 27, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 27, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 16, 2023DOCKASSIGNED TO EXAMINER—
Sep 21, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 5, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance